SPIRONOLACTONE W Drug Patent Profile
✉ Email this page to a colleague
When do Spironolactone W patents expire, and when can generic versions of Spironolactone W launch?
Spironolactone W is a drug marketed by Ivax Pharms, Lederle, Parke Davis, Purepac Pharm, Upsher Smith, Usl Pharma, Vangard, and Watson Labs. and is included in nine NDAs.
The generic ingredient in SPIRONOLACTONE W is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SPIRONOLACTONE W?
- What are the global sales for SPIRONOLACTONE W?
- What is Average Wholesale Price for SPIRONOLACTONE W?
Summary for SPIRONOLACTONE W
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| DailyMed Link: | SPIRONOLACTONE W at DailyMed |
US Patents and Regulatory Information for SPIRONOLACTONE W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Pharms | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087004-002 | May 24, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vangard | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087655-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Purepac Pharm | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 088054-001 | Aug 18, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
